| 2012-03 | KR-POK Interacts with p53 and Represses Its Ability to Activate Transcription of p21WAF1/CDKN1A | 윤채옥 |
| 2012-03 | Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers | 윤채옥 |
| 2013-03 | Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy | 윤채옥 |
| 2013-09 | Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy | 윤채옥 |
| 2018-06 | Mathematical Modelling of the Interaction Between Cancer Cells and an Oncolytic Virus: Insights into the Effects of Treatment Protocols | 윤채옥 |
| 2019-09 | Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma | 윤채옥 |
| 2020-01 | Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy | 윤채옥 |
| 2021-04 | Metformin Inhibits Transforming Growth Factor β–Induced Fibrogenic Response of Human Dermal Fibroblasts and Suppresses Fibrosis in Keloid Spheroids | 윤채옥 |
| 2011-10 | MicroRNA-296 is enriched in cancer cells and downregulates p21(WAF1) mRNA expression via interaction with its 3 ' untranslated region | 윤채옥 |
| 2016-11 | Mild Hyperthermia Induced by Gold Nanorod-Mediated Plasmonic Photothermal Therapy Enhances Transduction and Replication of Oncolytic Adenoviral Gene Delivery | 윤채옥 |
| 2018-10 | Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics | 윤채옥 |
| 2011-04 | Molecular characterization of apoptosis induced by CARF silencing in human cancer cells (vol 18, pg 589, 2011) | 윤채옥 |
| 2021-01 | Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane | 윤채옥 |
| 2021-01 | Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane | 윤채옥 |
| 2017-10 | Mortalin deficiency suppresses fibrosis and induces apoptosis in keloid spheroids | 윤채옥 |
| 2011-08 | Multifunctional Nanoparticles for Targeted Chemophotothermal Treatment of Cancer Cells | 윤채옥 |
| 2020-04 | Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma | 윤채옥 |
| 2011-08 | A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma | 윤채옥 |
| 2012-05 | A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer | 윤채옥 |
| 2013-01 | A novel three-dimensional model system for keloid study: Organotypic multicellular scar model | 윤채옥 |
| 2019-09 | Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT | 윤채옥 |
| 2011-09 | Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12R beta(2) or IL-18R alpha | 윤채옥 |
| 2015-07 | Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy | 윤채옥 |
| 2017-01 | Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model | 윤채옥 |
| 2015-12 | Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model | 윤채옥 |
| 2016-12 | Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function adn enhances antitumor efficacy. | 윤채옥 |
| 2013-07 | Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity | 윤채옥 |
| 2017-06 | Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer | 윤채옥 |
| 2020-11 | Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials | 윤채옥 |
| 2020-04 | Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells | 윤채옥 |
